KPMG's views on the new public policy environment in the United States: The impact on pharmaceutical and medical device companies

According to KPMG, change in healthcare policy is inevitable under the Obama administration. There is much speculation as to whether widespread reform will be implemented by the new leadership and if so, how and when this will occur. This eight-page special explores the impact of the new U.S. political environment on the pharmaceutical and medical devices industries.

Download the report here.